John Uribe has built a culture of collaboration across teams as Blue Cross and Blue Shield of Minnesota finds more efficient ...

For unresectable or metastatic liver cancer, the TPST-1120-301 trial of amezalpat combination therapy has received a “Study ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

PTC Therapeutics' gene therapy is already approved in the European ... while European stocks rose on hopes of a better growth ...

Net income of $1.5 millionAdjusted EBITDA1 of $1.9 millionADHD Portfolio net revenue up 1% to $15.3 millionPediatric Portfolio net revenue up 54% sequentially$20.1 million cash balance at September 30 ...

Robbins will be responsible for revenue, customer success, marketing, product management, engineering, and support.

Headquartered in Cambridge, the United Kingdom, Bicycle Therapeutics plc (NASDAQ:BCYC) is a clinical-stage biopharmaceutical ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Thank you for standing by and welcome to Heron Therapeutics ...

These three emerging technology leaders are pioneering quantum computing, gene editing, and electric aviation.

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

With consumer spending comprising 68% of the U.S. economy, analysts emphasized that a robust job market remains central to ...

Nov. 12, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq ... Voyager is committed to maintaining a strong balance ...